A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer

Local Institution, Greenville

Local Institution, Dallas

Local Institution, Tyler

Local Institution, San Antonio

Local Institution, San Antonio

Local Institution, Aurora

Local Institution, Fresno

Local Institution, Eugene

Local Institution, Beijing

Local Institution, Shenyang

Local Institution, New Haven

Local Institution, Boston

Local Institution, Nashville

Local Institution, Guangzhou

Local Institution, Changsha